Test Results For:

Carbohydrate Antigen 15-3 (CA 15-3)

Test Name

Carbohydrate Antigen 15-3 (CA 15-3)

Test Code
CA153

Short Description

CA 15-3

Test Name

Carbohydrate Antigen 15-3 (CA 15-3)

Test Code

CA153

Category

Immunoassay

TAT

Main Lab: 6 Hour(s)
Family Site: <8hrs, <6hrs

Specimen(s)

1 x Venous blood - 5 mL Tube - Gold - SST-Serum Separator Tube

Specimen Type

SST-Serum Separator Tube

Specimen Format

Tube

Specimen Colour

Gold

Specimen Volume

5 mL

Sampling Order

2

Origin

Venous blood

Collection Time after baseline

-

Transport Temperature

15-25°C

Accepted Other Specimens

Serum

TAT

Main Lab: 6 Hour(s)
Family Site: <8hrs, <6hrs

Test Stability

Room Temp: 24 Hour(s)
2–8°C: 5 Day(s)

Methodology

-

Specimen Type

SST-Serum Separator Tube

Other Type of Specimen Accepted

Serum

Delay before pre-treatment

6

Transport temperature

15-25°C

Test stability at room temperature

24 Hour(s)

Test stability at 2–8°C

5 Day(s)

Haemolysis interference

No


Clinical Interest

CA 15-3 is a protein produced by breast cancer cells and other cells in the body.
The main clinical interest in CA 15-3 lies in monitoring patients with metastatic breast cancer. CA 15-3 is elevated in approximately 70-80% of patients.

Increased levels may indicate disease progression or recurrence, while decreased levels suggest a favourable response to treatment (e.g. chemotherapy or hormone therapy).
CA 15-3 should not be used for the initial diagnosis of breast cancer, as it may be normal in the early stages of the disease, and elevated levels may be seen in other conditions.

Although most commonly used in breast cancer, CA 15-3 can be elevated in other malignancies:

  • ovarian cancer, lung cancer, liver cancer
  • or pancreatic cancer

CA 15-3 levels can also be elevated in non-cancerous conditions, but generally to a lesser extent.
Consequently, an elevated CA 15-3 level is not always an indication of malignancy and should be interpreted according to the clinical context.

Clinical Information Required

-


Patient Collection Note

-

LOINC Code

08-6, 8308-6, 83083-6

Outwork

No

Notification just now
URL copied to clipboard.
Find a Lab Now

Cerba Lancet Africa on the continent

Botswana Eswatini Ethiopia Gabon Ghana Ivory Coast Kenya Mozambique Nigeria Rwanda Tanzania Uganda Zambia Zimbabwe